Prognostic importance of emerging cardiac, inflammatory, and renal biomarkers in chronic heart failure patients with reduced ejection fraction and anaemia: RED ‐HF study

ConclusionOnce NT‐proBNP is included, only hsTnT moderately further improved risk stratification in this group of chronic heart failure with reduced ejection fraction patients with moderate anaemia. NT‐proBNP and hsTnT far outperform other emerging biomarkers in prediction of adverse outcome.

Source: European Journal of Heart Failure - September 27, 2017 Category: Cardiology Authors: Paul Welsh, Lei Kou, Changhong Yu, Inder Anand, Dirk J. van Veldhuisen, Aldo P. Maggioni, Akshay S. Desai, Scott D. Solomon, Marc A. Pfeffer, Sunfa Cheng, Lars Gullestad, P ål Aukrust, Thor Ueland, Karl Swedberg, James B. Young, Michael W. Kattan, Naveed Tags: Research Article Source Type: research